AMEX:RVP (USA)

Retractable Technologies Inc

$ 0.71 0.01 (1.35%)
Volume: 107,665 Avg Vol (1m): 231,256
Market Cap $: 23.15 Mil Enterprise Value $: 16.33 Mil
P/E (TTM): 0.00 P/B: 0.92
Earnings Power Value -0.02
Net Current Asset Value 0.36
Tangible Book 0.76
Projected FCF -0.07
Median P/S Value 1.06
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
YTD (-%)

Financial Strength : 7/10

Current vs industry vs history
Cash-to-Debt 3.49
Equity-to-Asset 0.70
Debt-to-Equity 0.12
Debt-to-EBITDA -10.54
Piotroski F-Score 5
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.10
DISTRESS
GREY
SAFE
Beneish M-Score 1.54
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC -9.69%
WACC 3.91%

Profitability & Growth : 3/10

Current vs industry vs history
Operating Margin % -4.75
Net Margin % -4.03
ROE % -7.78
ROA % -3.60
ROC (Joel Greenblatt) % -7.56
3-Year Total Revenue Growth Rate 4.00

» RVP's 30-Y Financials

Financials (Next Earnings Date: 2019-05-15)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with AMEX:RVP

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS : 339112    SIC : 3841
Compare ROCO:6493 SGX:41A AMEX:DXR NAS:PDEX BSP:BALM4 XKLS:0163 AMEX:ISR LSE:ODX OTCPK:NEPH AMEX:MLSS DHA:JMISMDL NAS:CASM XKLS:7191 ROCO:6527 NAS:MBOT TSE:3604 NAS:BIOL OTCPK:STXS HKSE:08513 IST:SEYKM
Traded in other countries
Address 511 Lobo Lane, Little Elm, TX, USA, 75068-5295
Retractable Technologies Inc designs, develops, manufactures, and market patented safety medical products for the healthcare industry. It offers 1mL tuberculin; insulin syringes; allergy antigen VanishPoint syringes; 0.5mL, 2mL, 3mL, 5mL, and 10mL VanishPoint syringes; EasyPoint needle, and the VanishPoint blood collection tube holder. It also sells VanishPoint auto-disable syringes in the international market in addition to its other products. The company distributes its products throughout the U.S. through the general line and specialty distributors. It also uses international distributors. The maximum revenue derives from US region sale.

Ratios

Current vs industry vs history
PB Ratio 0.92
PS Ratio 0.70
EV-to-EBIT -13.95
EV-to-EBITDA -56.75
EV-to-Revenue 0.49
Current Ratio 2.79
Quick Ratio 1.91
Days Inventory 113.15
Days Sales Outstanding 53.88
Days Payable 85.02

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -4.50

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 0.93
Price-to-Median-PS-Value 0.67
Earnings Yield (Joel Greenblatt) % -7.15

More Statistics

Revenue (TTM) (Mil) $ 33.28
EPS (TTM) $ -0.06
Beta 0.19
Volatility % 33.97
52-Week Range $ 0.54 - 1.34
Shares Outstanding (Mil) 32.67

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 5
Positive ROA N
Positive CFROA N
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy Y
Higher Gross Margin yoy Y
Higher Asset Turnover yoy N